CAMPASS: Benmelstobart in combination with anlotinib vs pembrolizumab in the first-line treatment of advanced non-small cell lung cancer (aNSCLC)—A randomized, single-blind, multicenter phase 3 study.

Compared with the traditional AC power transmission system, the short-circuit current of HVDC grid dc side do not has natural zero-crossing, rises rapidly and is larger. Fault current limitation ...